165 JNJ-26483327, a second-generation spectrum-targeted protein tyrosine kinase inhibitor with superior characteristics in advanced cancer models
| Autor: | Haefner, B., Geerts, T., Lavrijssen, T., Versele, M., King, P., Andries, L., Becker, F., Carmeliet, P., Perera, T. |
|---|---|
| Zdroj: | In EJC Supplements 2010 8(7):57-57 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect